PGP and dementia: Clinical data also support the role of P-gp in AD pathology, as positron-emission tomography (PET) studies have demonstrated that the P-gp transporter receptor is compromised in the BBB of AD patients and epidemiologic studies have illustrated an inverse correlation in Aβ plaque numbers and P-gp expression in patients without dementia [145].